造血干细胞移植后硬皮病样慢性移植物抗宿主病的临床表现  

Sclerodermatous chronic graft-versus-host disease after hematopoietic stem cell transplantation: incidence, clinical characteristics and risk factors

作　　者：杨欢[1] 李志涛[1] 林韧[1] 范志平[1] 黄芬[1] 江千里[1] 周红升[1] 刘启发[1] 孙竞[1] 

机构地区：[1]南方医科大学南方医院血液科//血液病研究所,广东广州510515

出　　处：《南方医科大学学报》2016年第6期807-813,共7页Journal of Southern Medical University

基　　金：广州市健康医疗协同创新重大专项(201400000003-4)

摘　　要：目的探讨异基因造血干细胞移植（allo-HSCT）后硬皮病样慢性移植物抗宿主病（Sc GVHD）的发病率、危险因素。方法对我院2012年1月～2014年12月之间进行allo-HSCT的259例患者发生Sc GVHD的情况进行回顾性分析。结果 134例（51.7%）发生慢性移植物抗宿主病（c GVHD）,其中22例为硬皮病型,即Sc GVHD在移植患者中的发病率为8.49%（22/259）、在c GVHD患者中的发病率为16.4%（22/134）。Sc GVHD出现的中位时间为移植后12.5（4～28）月。单因素分析结果提示预处理方案是否含全身照射（TBI）（P=0.031）、GVHD预防方案是否含霉酚酸酯（MMF）（P=0.046）、c GVHD（P=0.008）的发生、供者淋巴细胞回输（DLI）（P=0.001）均与Sc GVHD的发生具有相关性。多因素分析确定c GVHD[相对危险度（RR）=3.512,95%可信区间（CI）=1.235～9.987,P=0.018]和DLI（RR=5.217,95%CI=1.698～16.029,P=0.004）为Sc GVHD发病的独立危险因素。结论Sc GVHD是移植后一种较为少见的并发症,移植物抗宿主病（GVHD）和DLI是其发病的独立危险因素。Objective To investigate the incidence and risk factors of sclerodermatous chronic graft- versus- host disease（Sc GVHD） after allogeneic hematopoietic stem cell transplantation（allo- HSCT）. Methods The clinical data of 259 patients undergoing allo- HSCT in Nanfang Hospital between January, 2012 and December, 2014 were analyzed. Results Chronic GVHD following allo- HSCT occurred in 134（51.7%） cases, among whom 22 patients showed sclerodermatous features at a median of 12.5 months（range 4-28 months） after the transplantation. The overall incidence of Sc GVHD was 8.49%（22/259） in the recipients and 16.4%（22/134） in those with c GVHD. Univariate analysis showed that the conditioning regimen with total body irradiation（P=0.031）, GVHD prophylaxis with MMF（P=0.046）, presence of chronic GVHD（P=0.008）, and donor lymphocyte infusion（P=0.001） were all closely associated with the occurrence of Sc GVHD. Multivariate analysis identified chronic GVHD（RR=3.512, 95% CI： 1.235- 9.987, P=0.018） and donor lymphocyte infusion（RR=5.217, 95% CI： 1.698- 16.029, P=0.004） as the independent risk factors of Sc GVHD. Conclusion Sc GVHD following allo-HSCT is not a common complication,and c GVHD and donor lymphocyte infusion are the independent risk factors for Sc GVHD.

关 键 词：造血干细胞移植 硬皮病样移植物抗宿主病 临床特征 危险因素 

分 类 号：R457.7[医药卫生—治疗学]